Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Abstract

Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer.